Trials / Completed
CompletedNCT04767685
The Bern Perioperative Biobank
The Bern Perioperative Biobank to Define Perioperative Changes of Molecular Markers of Perioperative Organo-dysfunctions, Inflammation, Adverse Events and Disease Progression
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 547 (actual)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of the research is to define clinically relevant molecular markers for increased risk of peri-/ postoperative organo-dysfunctions, inflammation, adverse events and disease progression. To better understand the perioperative impact the investigators aim to determine perioperative levels of molecular markers over time in the available samples and clinical data of the Bern perioperative Biobank (BPBB) cohort to finally increase quality of perioperative care of patients by permitting preventive measures to be taken early in patients at risk.
Conditions
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2021-02-23
- Last updated
- 2022-11-15
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04767685. Inclusion in this directory is not an endorsement.